Bausch Health Companies Inc. Stock-Based Compensation
Bausch Health Companies Inc. (BHC) reported Stock-Based Compensation of $106.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-30
- Bausch Health Companies Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $54.00M, a 17.39% increase year-over-year.
- Bausch Health Companies Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $52.00M, a 20.93% increase year-over-year.
- Bausch Health Companies Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $84.00M, a 95.35% increase year-over-year.
- Bausch Health Companies Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $43.00M, a 13.16% increase year-over-year.
- Bausch Health Companies Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $216.00M, a 44.00% increase from fiscal 2024.
- Bausch Health Companies Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $150.00M, a 13.64% increase from fiscal 2023.
- Bausch Health Companies Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $132.00M, a 4.76% increase from fiscal 2022.
- Bausch Health Companies Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $126.00M, a 1.56% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $54.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $106.00M 10-Q · filed 2026-07-30 | $190.00M derived: sum of 3 quarters · filed 2026-07-30 | $233.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $52.00M 10-Q · filed 2026-04-30 | $136.00M derived: sum of 2 quarters · filed 2026-04-30 | $179.00M derived: sum of 3 quarters · filed 2026-04-30 | $225.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $84.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $127.00M derived: sum of 2 quarters · filed 2026-02-19 | $173.00M derived: sum of 3 quarters · filed 2026-07-30 | $216.00M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $43.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $89.00M derived: sum of 2 quarters · filed 2026-07-30 | $132.00M 10-Q · filed 2025-10-30 | $175.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $46.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $89.00M 10-Q · filed 2026-07-30 | $132.00M derived: sum of 3 quarters · filed 2026-07-30 | $170.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $43.00M 10-Q · filed 2026-04-30 | $86.00M derived: sum of 2 quarters · filed 2026-04-30 | $124.00M derived: sum of 3 quarters · filed 2026-04-30 | $160.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $81.00M derived: sum of 2 quarters · filed 2026-02-19 | $117.00M derived: sum of 3 quarters · filed 2026-02-19 | $150.00M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $38.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $74.00M derived: sum of 2 quarters · filed 2025-10-30 | $107.00M 10-Q · filed 2025-10-30 | $136.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $36.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $69.00M 10-Q · filed 2025-07-31 | $98.00M derived: sum of 3 quarters · filed 2026-02-19 | $127.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $33.00M 10-Q · filed 2025-05-01 | $62.00M derived: sum of 2 quarters · filed 2026-02-19 | $91.00M derived: sum of 3 quarters · filed 2026-02-19 | $124.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $58.00M derived: sum of 2 quarters · filed 2026-02-19 | $91.00M derived: sum of 3 quarters · filed 2026-02-19 | $132.00M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $29.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $62.00M derived: sum of 2 quarters · filed 2024-10-31 | $103.00M 10-Q · filed 2024-10-31 | $138.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $33.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $74.00M 10-Q · filed 2024-08-01 | $109.00M derived: sum of 3 quarters · filed 2025-02-20 | $142.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $41.00M 10-Q · filed 2024-05-02 | $76.00M derived: sum of 2 quarters · filed 2025-02-20 | $109.00M derived: sum of 3 quarters · filed 2025-02-20 | $135.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $35.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $68.00M derived: sum of 2 quarters · filed 2025-02-20 | $94.00M derived: sum of 3 quarters · filed 2025-02-20 | $126.00M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $33.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $59.00M derived: sum of 2 quarters · filed 2023-11-02 | $91.00M 10-Q · filed 2023-11-02 | $124.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $26.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $58.00M 10-Q · filed 2023-08-03 | $91.00M derived: sum of 3 quarters · filed 2024-02-22 | $124.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $32.00M 10-Q · filed 2023-05-04 | $65.00M derived: sum of 2 quarters · filed 2024-02-22 | $98.00M derived: sum of 3 quarters · filed 2024-02-22 | $129.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $66.00M derived: sum of 2 quarters · filed 2024-02-22 | $97.00M derived: sum of 3 quarters · filed 2024-02-22 | $128.00M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $33.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $64.00M derived: sum of 2 quarters · filed 2022-11-03 | $95.00M 10-Q · filed 2022-11-03 | $119.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $31.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $62.00M 10-Q · filed 2022-08-09 | $86.00M derived: sum of 3 quarters · filed 2023-02-23 | $113.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $31.00M 10-Q · filed 2022-05-10 | $55.00M derived: sum of 2 quarters · filed 2023-02-23 | $82.00M derived: sum of 3 quarters · filed 2023-02-23 | $109.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $51.00M derived: sum of 2 quarters · filed 2023-02-23 | $78.00M derived: sum of 3 quarters · filed 2023-02-23 | $105.00M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $27.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $54.00M derived: sum of 2 quarters · filed 2021-11-02 | $81.00M 10-Q · filed 2021-11-02 | $106.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | $27.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $54.00M 10-Q · filed 2021-08-03 | $79.00M derived: sum of 3 quarters · filed 2022-05-11 | $105.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | $27.00M 10-Q · filed 2021-05-04 | $52.00M derived: sum of 2 quarters · filed 2022-05-11 | $78.00M derived: sum of 3 quarters · filed 2022-05-11 | $105.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | $25.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $51.00M derived: sum of 2 quarters · filed 2022-05-11 | $78.00M derived: sum of 3 quarters · filed 2022-05-11 | $102.00M 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | $26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $53.00M derived: sum of 2 quarters · filed 2020-11-03 | $77.00M 10-Q · filed 2020-11-03 | $99.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $27.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $51.00M 10-Q · filed 2020-08-06 | $73.00M derived: sum of 3 quarters · filed 2021-05-04 | $95.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $24.00M 10-Q · filed 2020-05-07 | $46.00M derived: sum of 2 quarters · filed 2021-05-04 | $68.00M derived: sum of 3 quarters · filed 2021-05-04 | $90.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | $22.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $44.00M derived: sum of 2 quarters · filed 2021-05-04 | $66.00M derived: sum of 3 quarters · filed 2021-05-04 | $87.00M 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | $22.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $44.00M derived: sum of 2 quarters · filed 2019-11-04 | $65.00M 10-Q · filed 2019-11-04 | $82.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $22.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $43.00M 10-Q · filed 2019-08-06 | $60.00M derived: sum of 3 quarters · filed 2020-02-19 | $79.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $21.00M 10-Q · filed 2019-05-06 | $38.00M derived: sum of 2 quarters · filed 2020-02-19 | $57.00M derived: sum of 3 quarters · filed 2020-02-19 | $80.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $36.00M derived: sum of 2 quarters · filed 2020-02-19 | $59.00M derived: sum of 3 quarters · filed 2020-02-19 | $87.00M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $19.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $42.00M derived: sum of 2 quarters · filed 2018-11-06 | $70.00M 10-Q · filed 2018-11-06 | $101.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $51.00M 10-Q · filed 2018-08-07 | $82.00M derived: sum of 3 quarters · filed 2019-02-20 | $119.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $28.00M 10-Q · filed 2018-05-08 | $59.00M derived: sum of 2 quarters · filed 2019-02-20 | $96.00M derived: sum of 3 quarters · filed 2019-02-20 | $129.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $68.00M derived: sum of 2 quarters · filed 2019-02-20 | $101.00M derived: sum of 3 quarters · filed 2019-02-20 | $165.00M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | $37.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $70.00M derived: sum of 2 quarters · filed 2017-11-07 | $134.00M 10-Q · filed 2017-11-07 | $162.60M derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2016-06-30 | $33.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $97.00M 10-Q · filed 2017-08-08 | $97.20M 10-Q · filed 2016-08-09 | $125.60M derived: sum of 3 quarters · filed 2018-08-10 | $176.10M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | $64.00M 10-Q · filed 2017-05-09 | $63.50M 10-Q · filed 2016-06-07 | $92.60M derived: sum of 2 quarters · filed 2018-08-10 | $143.10M derived: sum of 3 quarters · filed 2018-08-10 | $169.00M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $28.60M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $79.10M derived: sum of 2 quarters · filed 2018-08-10 | $105.00M derived: sum of 3 quarters · filed 2018-08-10 | $140.00M 8-K · filed 2018-08-10 | $140.10M 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $50.50M 10-Q · filed 2015-10-26 | $76.40M derived: sum of 2 quarters · filed 2015-10-26 | $111.40M 10-Q · filed 2016-11-09 | $128.80M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $25.90M 10-Q · filed 2015-07-28 | $60.90M 10-Q · filed 2016-08-09 | $78.30M derived: sum of 3 quarters · filed 2017-03-01 | $98.50M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $35.00M 10-Q · filed 2016-06-07 | $52.40M derived: sum of 2 quarters · filed 2017-03-01 | $72.60M derived: sum of 3 quarters · filed 2017-03-01 | $88.20M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $17.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $37.60M derived: sum of 2 quarters · filed 2017-03-01 | $53.20M derived: sum of 3 quarters · filed 2017-03-01 | $78.00M 10-K · filed 2017-03-01 | $78.20M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $20.20M 10-Q · filed 2015-10-26 | $35.80M derived: sum of 2 quarters · filed 2015-10-26 | $60.60M 10-Q · filed 2015-10-26 | $73.60M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $15.60M 10-Q · filed 2015-07-28 | $40.40M 10-Q · filed 2015-07-28 | $53.40M derived: sum of 3 quarters · filed 2016-04-29 | $69.40M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $24.80M 10-Q · filed 2015-04-30 | $37.80M derived: sum of 2 quarters · filed 2016-04-29 | $53.80M derived: sum of 3 quarters · filed 2016-04-29 | $61.20M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $29.00M derived: sum of 2 quarters · filed 2016-04-29 | $36.40M derived: sum of 3 quarters · filed 2016-04-29 | $45.50M 10-K · filed 2016-04-29 | $45.48M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $16.00M 10-Q · filed 2014-10-24 | $23.40M derived: sum of 2 quarters · filed 2014-10-24 | $32.50M 10-Q · filed 2014-10-24 | $32.48M 10-Q · filed 2013-11-01 | $45.84M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2013-06-30 | $7.40M 10-Q · filed 2014-08-01 | $7.38M 10-Q · filed 2013-08-07 | $16.50M 10-Q · filed 2014-08-01 | $16.48M 10-Q · filed 2013-08-07 | $29.84M derived: sum of 3 quarters · filed 2015-02-25 | $48.39M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $9.10M 10-Q · filed 2014-05-09 | $9.10M 10-Q · filed 2013-05-03 | $22.45M derived: sum of 2 quarters · filed 2015-02-25 | $40.99M derived: sum of 3 quarters · filed 2015-02-25 | $56.15M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $13.35M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $31.89M derived: sum of 2 quarters · filed 2015-02-25 | $47.05M derived: sum of 3 quarters · filed 2015-02-25 | $66.20M 10-K · filed 2015-02-25 | $66.24M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $18.55M 10-Q · filed 2013-11-01 | $33.70M derived: sum of 2 quarters · filed 2013-11-01 | $52.85M 10-Q · filed 2013-11-01 | $73.84M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $15.16M 10-Q · filed 2013-08-07 | $34.31M 10-Q · filed 2013-08-07 | $55.29M derived: sum of 3 quarters · filed 2014-02-28 | $72.88M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $19.15M 10-Q · filed 2013-05-03 | $40.14M derived: sum of 2 quarters · filed 2014-02-28 | $57.72M derived: sum of 3 quarters · filed 2014-02-28 | $83.28M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $20.98M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $38.57M derived: sum of 2 quarters · filed 2014-02-28 | $64.13M derived: sum of 3 quarters · filed 2014-02-28 | $94.02M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $17.59M 10-Q · filed 2012-11-05 | $43.15M derived: sum of 2 quarters · filed 2012-11-05 | $73.04M 10-Q · filed 2012-11-05 | $99.23M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $25.56M 10-Q · filed 2012-08-03 | $55.45M 10-Q · filed 2012-08-03 | $81.65M derived: sum of 3 quarters · filed 2013-02-28 | $149.93M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $29.89M 10-Q · filed 2012-05-04 | $56.09M derived: sum of 2 quarters · filed 2013-02-28 | $124.37M derived: sum of 3 quarters · filed 2013-02-28 | $126.27M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $26.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $94.48M derived: sum of 2 quarters · filed 2013-02-28 | $96.38M derived: sum of 3 quarters · filed 2013-02-28 | $98.03M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $68.28M 10-Q · filed 2011-11-04 | $70.18M derived: sum of 2 quarters · filed 2011-11-04 | $71.84M 10-Q · filed 2011-11-04 | $73.23M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-06-30 | $1.90M 10-Q · filed 2011-08-08 | $3.55M 10-Q · filed 2011-08-08 | $4.95M derived: sum of 3 quarters · filed 2012-02-29 | $6.07M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-03-31 | $1.66M 10-Q · filed 2011-05-10 | $3.05M derived: sum of 2 quarters · filed 2012-02-29 | $4.18M derived: sum of 3 quarters · filed 2012-02-29 | $5.51M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $2.52M derived: sum of 2 quarters · filed 2012-02-29 | $3.86M derived: sum of 3 quarters · filed 2012-02-29 | $5.61M 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $1.13M 10-Q · filed 2010-11-05 | $2.46M derived: sum of 2 quarters · filed 2010-11-05 | $4.22M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $1.33M 10-Q · filed 2010-08-06 | $3.09M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | $7.91M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |